Hims & Hers able to scale peptide offering if US law allows, CFO says
10/08/2026 22:08
Hims & Hers able to scale peptide offering if US law allows, CFO says NEW YORK, Aug 10 (Reuters) - Hims & Hers Health CFO Yemi Okupe said on Monday the telehealth company could rapidly sell peptide products at scale, if U.S. regulation allows.
(Reporting by Amina Niasse; Editing by Diti Pujara)
Recent news on Hims & Hers Health
See all newsBrief: Hims & Hers Health Expands Testosterone Care With Injectable And Oral TRT
Hims & Hers Health launches online weight management service for men in Germany
Corrected: US FDA takes step to change peptide compounding policy (Oct 15)
Brief: Hims & Hers Names Jon Franklin As Chief Accounting Officer
Brief: Hims & Hers Names Chief Medical Officers In The Uk And Australia, Deepening Its Investment In Local Clinical Leadership